Morgan Stanley’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-875
Closed 8115
2022
Q3
$0 Sell
875
-10,000
-92% -$4.85K ﹤0.01% 8100
2022
Q2
$5K Buy
10,875
+875
+9% +$637 ﹤0.01% 7427
2022
Q1
$8K Buy
+10,000
New +$7.08K ﹤0.01% 7487

Morgan Stanley's CRHC.WS Position: Q4 2022 in Review

Morgan Stanley sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q4 2022, closing a stake of 875 shares.

Morgan Stanley first reported a position in CRHC.WS in Q1 2022 and held it in 3 quarters. The position peaked at $8K in Q1 2022. 0 funds tracked by Wall St. Rank hold CRHC.WS as of Q4 2022.

  • Morgan Stanley reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 875 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022.
  • Morgan Stanley first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Morgan Stanley's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $8K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.